Comments
Loading...

Heron Therapeutics Analyst Ratings

HRTXNASDAQ
Logo brought to you by Benzinga Data
$1.97
0.15.35%
At close: -
$1.94
-0.03-1.50%
After Hours: May 16, 7:41 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$10.00
Lowest Price Target1
$4.00
Consensus Price Target1
$6.75

Heron Therapeutics Analyst Ratings and Price Targets | NASDAQ:HRTX | Benzinga

Heron Therapeutics Inc has a consensus price target of $6.75 based on the ratings of 4 analysts. The high is $10 issued by Evercore ISI Group on March 24, 2023. The low is $4 issued by Needham on April 11, 2025. The 3 most-recent analyst ratings were released by Needham on April 11, 2025, February 28, 2025, and December 4, 2024, respectively. With an average price target of $4 between Needham, there's an implied 106.14% upside for Heron Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Dec 24
1
Feb
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Needham
Rodman & Renshaw
Capital One
Evercore ISI Group

1calculated from analyst ratings

Analyst Ratings for Heron Therapeutics

Buy NowGet Alert
04/11/2025Buy Now106.14%Needham
Serge Belanger65%
$4 → $4ReiteratesBuy → BuyGet Alert
02/28/2025Buy Now106.14%Needham
Serge Belanger65%
$4 → $4ReiteratesBuy → BuyGet Alert
12/04/2024Buy Now106.14%Needham
Serge Belanger65%
$4 → $4ReiteratesBuy → BuyGet Alert
11/13/2024Buy Now106.14%Needham
Serge Belanger65%
$5 → $4MaintainsBuyGet Alert
09/25/2024Buy Now157.68%Needham
Serge Belanger65%
$5 → $5ReiteratesBuy → BuyGet Alert
08/07/2024Buy Now157.68%Needham
Serge Belanger65%
$5 → $5ReiteratesBuy → BuyGet Alert
06/13/2024Buy Now260.75%Rodman & Renshaw
Brandon Folkes38%
→ $7Initiates → BuyGet Alert
05/16/2024Buy Now157.68%Needham
Serge Belanger65%
$5 → $5ReiteratesBuy → BuyGet Alert
05/08/2024Buy Now157.68%Needham
Serge Belanger65%
$5 → $5ReiteratesBuy → BuyGet Alert
04/23/2024Buy Now209.21%Capital One
Tim Chiang37%
→ $6Initiates → OverweightGet Alert
04/11/2024Buy Now157.68%Needham
Serge Belanger65%
$5 → $5ReiteratesBuy → BuyGet Alert
03/13/2024Buy Now157.68%Needham
Serge Belanger65%
$4 → $5MaintainsBuyGet Alert
11/15/2023Buy Now106.14%Needham
Serge Belanger65%
$5 → $4MaintainsBuyGet Alert
08/15/2023Buy Now157.68%Needham
Serge Belanger65%
→ $5ReiteratesBuy → BuyGet Alert
07/25/2023Buy Now157.68%Needham
Serge Belanger65%
$6 → $5MaintainsBuyGet Alert
05/12/2023Buy Now209.21%Needham
Serge Belanger65%
$7 → $6MaintainsBuyGet Alert
04/21/2023Buy Now260.75%Needham
Serge Belanger65%
→ $7Reiterates → BuyGet Alert
03/24/2023Buy Now415.36%Evercore ISI Group
Shweta Khajuria58%
$15 → $10MaintainsOutperformGet Alert
03/24/2023Buy Now260.75%Needham
Serge Belanger65%
$8 → $7MaintainsBuyGet Alert
11/09/2022Buy Now312.29%Needham
Serge Belanger65%
$10 → $8MaintainsBuyGet Alert
06/30/2022Buy Now415.36%Needham
Serge Belanger65%
$14 → $10MaintainsBuyGet Alert

FAQ

Q

What is the target price for Heron Therapeutics (HRTX) stock?

A

The latest price target for Heron Therapeutics (NASDAQ:HRTX) was reported by Needham on April 11, 2025. The analyst firm set a price target for $4.00 expecting HRTX to rise to within 12 months (a possible 106.14% upside). 7 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Heron Therapeutics (HRTX)?

A

The latest analyst rating for Heron Therapeutics (NASDAQ:HRTX) was provided by Needham, and Heron Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Heron Therapeutics (HRTX)?

A

There is no last upgrade for Heron Therapeutics

Q

When was the last downgrade for Heron Therapeutics (HRTX)?

A

There is no last downgrade for Heron Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Heron Therapeutics (HRTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Heron Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Heron Therapeutics was filed on April 11, 2025 so you should expect the next rating to be made available sometime around April 11, 2026.

Q

Is the Analyst Rating Heron Therapeutics (HRTX) correct?

A

While ratings are subjective and will change, the latest Heron Therapeutics (HRTX) rating was a reiterated with a price target of $4.00 to $4.00. The current price Heron Therapeutics (HRTX) is trading at is $1.94, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch